Vanguard Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
139,776
-973
| -0.7% | -$7.02K | ﹤0.01% | 3741 |
|
|
2025
Q1 | $1.16M | Buy |
140,749
+43,987
| +45% | +$363K | ﹤0.01% | 3668 |
|
|
2024
Q4 | $3.85M | Buy |
96,762
+32,948
| +52% | +$1.31M | ﹤0.01% | 3366 |
|
|
2024
Q3 | $553K | Hold |
63,814
| – | – | ﹤0.01% | 3949 |
|
|
2024
Q2 | $558K | Buy |
63,814
+23,291
| +57% | +$204K | ﹤0.01% | 3971 |
|
|
2024
Q1 | $993K | Buy |
40,523
+57
| +0.1% | +$1.4K | ﹤0.01% | 3815 |
|
|
2023
Q4 | $672K | Buy |
40,466
+41
| +0.1% | +$681 | ﹤0.01% | 3948 |
|
|
2023
Q3 | $755K | Buy |
40,425
+637
| +2% | +$11.9K | ﹤0.01% | 3929 |
|
|
2023
Q2 | $966K | Sell |
39,788
-879
| -2% | -$21.3K | ﹤0.01% | 3912 |
|
|
2023
Q1 | $889K | Buy |
40,667
+127
| +0.3% | +$2.78K | ﹤0.01% | 3955 |
|
|
2022
Q4 | $966K | Sell |
40,540
-3,060
| -7% | -$72.9K | ﹤0.01% | 3926 |
|
|
2022
Q3 | $1.2M | Buy |
43,600
+1,093
| +3% | +$30.1K | ﹤0.01% | 3944 |
|
|
2022
Q2 | $1.29M | Sell |
42,507
-8,884
| -17% | -$269K | ﹤0.01% | 4000 |
|
|
2022
Q1 | $2.76M | Sell |
51,391
-3,606
| -7% | -$194K | ﹤0.01% | 3818 |
|
|
2021
Q4 | $16.3M | Buy |
54,997
+3,988
| +8% | +$1.18M | ﹤0.01% | 2949 |
|
|
2021
Q3 | $19.8M | Buy |
51,009
+11,677
| +30% | +$4.53M | ﹤0.01% | 2869 |
|
|
2021
Q2 | $20M | Buy |
39,332
+14,742
| +60% | +$7.51M | ﹤0.01% | 2844 |
|
|
2021
Q1 | $14M | Buy |
24,590
+162
| +0.7% | +$92.1K | ﹤0.01% | 2970 |
|
|
2020
Q4 | $16.9M | Buy |
+24,428
| New | +$16.9M | ﹤0.01% | 2727 |
|